# North America Pharmaceutical Logistics Market

> North America Pharmaceutical Logistics Market Research Report Information By Product (Generic Drugs, Branded Drugs), By Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), By Application (Bio Pharma, Chemical Pharma, Specialized Pharma), By Mode of Transport (Air Shipping, Rail Shipping, Road Shipping, Sea Shipping)–and North America Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.6%
- **2024:** $ 28.76 Billion
- **2025:** $ 33.16 Billion
- **2035:** $ 71.28 Billion
- **Key Players:** McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), UPS Healthcare (US), FedEx Corporation (US), DHL Supply Chain (US), Thermo Fisher Scientific Inc. (US), Panalpina (US)

**Report ID:** MRFR/PCM/19933-HCR · **Pages:** 128 · **Author:** Pradeep Nandi · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/north-america-pharmaceutical-logistics-market-21532

---

## Market Summary

## **North America Pharmaceutical Logistics Market Overview**

North America Pharmaceutical Logistics Market Size was valued at USD 76.59 Billion in 2024. The North America Pharmaceutical Logistics industry is projected to grow from USD 82.72 Billion in 2025 to USD 165.39 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 8.0% during the forecast period (2025 - 2034). The necessity for effective supply chain management is one of the major market drivers driving the North America Pharmaceutical Logistics market in North America.

North America Pharmaceutical Logistics is being adopted by industries due to its capacity, the rise in the outsourcing of logistical services, and the need for pharmaceutical products.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **North America Pharmaceutical Logistics Market Trends**

Pharmaceutical items are in high demand in North America due to the region's expanding population, aging demography, and increased incidence of chronic illnesses. As a result of the growing demand, prompt delivery of medications to patients and healthcare facilities relies on efficient logistics and supply chain management. Logistics companies are taking the lead in implementing renewable energy into their operations to lessen the environmental impact of temperature-controlled biopharma supply chains. Sustainable cold chain strategies are being implemented through the use of bio-based insulation, energy-efficient warehouses, green reefer trucks, solar, wind, or fuel cell-powered facilities, and more.

The biopharmaceutical business has grown substantially, fueled by the development of innovative biological medications and treatments. Strong pipeline expansion and new product approvals were caused by the introduction of biologics, such as recombinant proteins, cell and gene treatments, and monoclonal antibodies. This made temperature-controlled logistics more important to preserve product integrity during storage and transit.

Furthermore, to ensure the stability and effectiveness of biopharmaceutical products, cold chain logistics is a crucial component of their distribution. Supply chain visibility, security, and efficiency are being improved by developments in cold chain technologies, such as temperature-controlled packaging, real-time monitoring systems, GPS trackers, IoT integration, and automation. For biologics, advanced freezing methods like cryogenic freezing provide the best preservation. Extended thermal protection is provided by innovative packaging methods, including phase change materials and vacuum-insulated panels (VIPs). Temperature-controlled biopharma distribution entails significant expenses for value-added services, infrastructure, and specialist handling.

Regulatory compliance obligations, multi-modal shipping, complex worldwide operations, and an emphasis on reducing product loss all contribute to higher logistics costs. Costs are also affected by seasonal variations in demand and restricted transportation connectivity in some areas. Thus, driving the North America Pharmaceutical Logistics market revenue.

## **North America Pharmaceutical Logistics Market Segment Insights:**

### **North America Pharmaceutical Logistics Product Insights**

The North America Pharmaceutical Logistics market segmentation, based on Product, includes Generic Drugs and branded Drugs. The branded drugs segment dominated the market. This is because pharmaceutical corporations are the ones who create and market these drugs under their brands. Patents safeguard branded medications, granting the producer the sole authority to create and market the drug for a predetermined amount of time.

**Figure 1: North America Pharmaceutical Logistics Market, by Product, 2023 & 2032 (USD Billion)**

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **North America Pharmaceutical Logistics Mode of Operation Insights**

The North America Pharmaceutical Logistics market segmentation, based on Mode of Operation, includes Cold Chain Transport and Non-Cold Chain Transport. Cold Chain Transport generated the most income. This is because the term "pharmaceutical cold chain logistics" refers to an intricate, methodical operation in which, before being consumed by consumers, perishable medications and those requiring a low-temperature environment are constantly gathered in an environment with certain temperature ranges at each stage.

### **North America Pharmaceutical Logistics Application Insights**

The North America Pharmaceutical Logistics market segmentation, based on Application, includes Bio Pharma, Chemical Pharma, and Specialized Pharma. The Chemical Pharma segment dominated the market. This is due in part to biopharma's growing popularity in the [pharmaceutical](../../../reports/pharmaceutical-packaging-market-1291) business and its potential to treat illnesses with negligible to no adverse effects. Biopharma logistics will, therefore, be in great demand in the future.

### **North America Pharmaceutical Logistics Mode of Transport Insights**

The North America Pharmaceutical Logistics market segmentation, based on Mode of Transport, includes Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping. The Air Shipping segment dominated the market. This is because of its ability to deliver pharmaceutical products efficiently and quickly over long distances. Additionally, air travel offers temperature-controlled conditions for the transfer of temperature-sensitive medicines, which makes it a popular mode of transportation for these goods.

### **North America Pharmaceutical Logistics Country Insights**

The aging population, improvements in medical technology, and rising rates of chronic illnesses have made the United States one of the countries with the highest healthcare costs in the world. Pharmaceutical products are in greater demand as a result, which calls for effective supply chain management and logistics. The United States' pharmaceutical distribution landscape has changed due to the rise of e-commerce and online pharmacies. The simplicity of obtaining drugs online is becoming more and more appealing to consumers, which increases the demand for dependable and effective pharmaceutical logistics services to fulfill these purchases.

In order to improve access to prescription drugs and healthcare services, the United States healthcare system is placing an increasing emphasis on patient-centric care. In order to guarantee the prompt delivery of pharmaceuticals to healthcare facilities, pharmaceutical logistics is essential.

**Figure 2: North America Pharmaceutical Logistics Market Share By Region 2023 & 2032 (USD Billion)**

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **North America Pharmaceutical Logistics Key Market Players & Competitive Insights**

Leading market players are putting a lot of money into R&D to increase the range of products they sell, which will support further growth in the North America Pharmaceutical Logistics market. In addition, market players are engaging in a range of calculated initiatives to increase their presence, with significant market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. to grow and endure in an increasingly cutthroat and dynamic market, North America Pharmaceutical Logistics industry must provide reasonably priced goods.

Major players in the North America Pharmaceutical Logistics market are engaging in research and development activities in an effort to boost market demand, including Deutsche Post DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service Inc., C.H. Robinson Worldwide Inc., CEVA Logistics, DB Schenker, Agility Logistics, Air Canada.

### **Key Companies in the North America Pharmaceutical Logistics market include**

## **North America Pharmaceutical Logistics Industry Developments**

**In April 2023** when Panalpina, one of the prominent logistics service providers, also received news of its intention to merge with DHL Supply Chain. This strategy is focused on elevating the logistics performance of the pharmaceutical firms, particularly the cold chain logistics of such temperature-sensitive products. By means of the merger, operational efficiency and the logistics network in North America will be improved.

Looking at the **July 2023** picture, McKesson Corporation completed the purchase of Change Healthcare. This $13 Billion acquisition targets improvement of healthcare logistics, especially in the distribution of pharmaceutical products. The Partners also intend to improve supply chain visibility and better healthcare by employing Change healthcare within its supply chain.

The month of **September 2023** came along with announcements from AmerisourceBergen on their partnership with Celerion, a contract research organization (CRO) for the enhancement of clinical trial supply logistics. This partnership works on switching the supply of drugs to research centers and clinical sites and minimizes the time lost in getting medicines needed for studies. This partnership is likely to enhance their abilities in the management of complex logistics during clinical studies.

**In January 2024,** Cardinal Health and Genentech signed a merger agreement intending to improve their collaboration in the area of supply chain management. As a result of the merger, a powerful company focusing on logistics and the supply chain of biopharmaceuticals would be created with a special concentration on specialty pharmaceuticals where distribution is the essence of the product​.

Also, Ryder System, Inc. announced plans of acquisition of C3S, a pharmaceutical logistics provider, in February 2024. This acquisition is likely to add more value to Ryder’s portfolio as well as help increase the range of services offered, especially in the area of temperature-controlled logistics essential for the pharmaceutical industry​.

## **North America Pharmaceutical Logistics Market Segmentation**

### **North America Pharmaceutical Logistics Product Outlook**

### **North America Pharmaceutical Logistics Mode of Operation Outlook**

### **North America Pharmaceutical Logistics Application Outlook**

### **North America Pharmaceutical Logistics Mode of Transport Outlook**

### **North America Pharmaceutical Logistics Regional Outlook**

## Market Drivers

### Growth of E-commerce in Pharmaceuticals

The rise of e-commerce is significantly influencing the North America Pharmaceutical Logistics Market, as more consumers turn to online platforms for purchasing medications and health products. In 2025, e-commerce sales in the pharmaceutical sector reached an estimated $50 billion, reflecting a growing trend towards digital transactions. This shift necessitates logistics providers to adapt their services to accommodate direct-to-consumer deliveries, which often require expedited shipping and specialized handling. As a result, companies are investing in last-mile delivery solutions and enhancing their distribution networks to meet consumer expectations for speed and reliability. This evolving landscape presents both challenges and opportunities for logistics providers, as they strive to keep pace with the demands of the e-commerce market.

### Technological Advancements in Logistics

Technological innovations are reshaping the North America Pharmaceutical Logistics Market, with advancements such as automation, artificial intelligence, and blockchain playing pivotal roles. In 2025, approximately 30% of logistics companies in the pharmaceutical sector reported utilizing AI-driven analytics to optimize supply chain operations. These technologies facilitate improved inventory management, predictive analytics, and enhanced visibility throughout the logistics process. Furthermore, blockchain technology is being explored for its potential to enhance traceability and security in the supply chain, addressing concerns related to counterfeit drugs. As these technologies continue to evolve, they are expected to drive efficiency and reduce operational costs, thereby benefiting the overall pharmaceutical logistics landscape.

### Increasing Demand for Biopharmaceuticals

The North America Pharmaceutical Logistics Market is experiencing a notable surge in demand for biopharmaceuticals, driven by advancements in biotechnology and personalized medicine. As biopharmaceuticals often require specialized handling and storage conditions, logistics providers are adapting their services to meet these needs. In 2025, the biopharmaceutical sector accounted for approximately 40% of the total pharmaceutical market in North America, indicating a significant shift towards these complex products. This trend necessitates enhanced logistics capabilities, including temperature-controlled transport and real-time monitoring systems, to ensure product integrity throughout the supply chain. Consequently, logistics companies are investing in advanced technologies and infrastructure to cater to this growing segment, thereby propelling the overall market forward.

### Focus on Sustainability and Green Logistics

Sustainability is becoming an increasingly important consideration in the North America Pharmaceutical Logistics Market, as companies seek to reduce their environmental impact. In 2025, nearly 25% of logistics firms reported implementing green initiatives, such as optimizing transportation routes and utilizing eco-friendly packaging materials. This focus on sustainability is driven by both regulatory pressures and consumer demand for environmentally responsible practices. As pharmaceutical companies aim to align their operations with sustainability goals, logistics providers are adapting their strategies to support these initiatives. This trend not only enhances corporate social responsibility but also presents opportunities for cost savings through improved efficiency and reduced waste, ultimately benefiting the entire pharmaceutical supply chain.

### Regulatory Compliance and Quality Assurance

Regulatory compliance remains a critical driver in the North America Pharmaceutical Logistics Market, as stringent regulations govern the transportation and storage of pharmaceutical products. The U.S. Food and Drug Administration (FDA) and other regulatory bodies impose rigorous standards to ensure the safety and efficacy of drugs. In 2025, compliance-related costs accounted for nearly 15% of total logistics expenditures in the pharmaceutical sector. This has led logistics providers to enhance their quality assurance processes, implement robust tracking systems, and invest in employee training to adhere to these regulations. As a result, companies that prioritize compliance are likely to gain a competitive edge, fostering trust among stakeholders and ensuring uninterrupted supply chains.

## Future Outlook

The North America Pharmaceutical Logistics Market is projected to grow at an 8.6% CAGR from 2025 to 2035, driven by technological advancements, regulatory changes, and increasing demand for temperature-sensitive products.

**New opportunities:**

- Integration of AI-driven [supply chain management](https://www.marketresearchfuture.com/reports/supply-chain-management-market-21742) systems. Expansion of cold chain logistics for biologics and vaccines. Development of blockchain solutions for enhanced traceability and security.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in pharmaceutical logistics.

## Segment Insights

### By Application: Cold Chain Logistics (Largest) vs. Non-Cold Chain Logistics (Fastest-Growing)

In the North America Pharmaceutical Logistics Market, Cold Chain Logistics holds the largest market share, driven by the critical need for temperature-sensitive medications and vaccines. This segment encompasses specialized transportation and storage processes that maintain specific temperature ranges, ensuring product efficacy and safety. Non-Cold Chain Logistics, while smaller in share, is rapidly gaining attention as more pharmaceutical products do not require stringent temperature controls, thus presenting new opportunities for growth. 
Recent trends indicate a significant shift towards automation and technology integration within both Cold and Non-Cold Chain Logistics. Cold Chain services have seen substantial investments to enhance efficiency, while Non-Cold Chain Logistcs is fueled by the increasing adoption of advanced logistics solutions, allowing companies to optimize their supply chains and reduce costs considerably.

Cold Chain Logistics (Dominant) vs. Transportation Management (Emerging)

Cold Chain Logistics stands as the dominant force within the North American Pharmaceutical Logistics Market, characterized by its specialized temperature-controlled environments essential for the delivery of sensitive pharmaceuticals. This segment benefits from the stringent regulations and guidelines enforced by health authorities, propelling the need for reliable cold storage and transportation solutions. On the other hand, Transportation Management is classified as an emerging segment, playing a pivotal role in optimizing the logistics network. It includes advanced planning and execution capabilities that streamline operations, reduce delays, and enhance traceability. Companies are increasingly investing in Transportation Management technologies as they emphasize efficient logistics operations, which ultimately support the complex requirements of pharmaceutical distribution.

### By End Use: Pharmaceutical Manufacturers (Largest) vs. Third Party Logistics Providers (Fastest-Growing)

The North America Pharmaceutical Logistics Market exhibits a diverse end-user landscape, with pharmaceutical manufacturers commanding the largest market share. This segment is primarily driven by the need for cold chain logistics owing to the sensitive nature of pharmaceutical products. In contrast, third party logistics providers are witnessing rapid growth as they offer scalable solutions that meet the complex distribution needs of pharmaceutical companies, thus serving as an essential link in the supply chain.

Pharmaceutical Manufacturers (Dominant) vs. Third Party Logistics Providers (Emerging)

Pharmaceutical manufacturers are the dominant players in the North America Pharmaceutical Logistics Market, characterized by high capital investment and stringent regulatory compliance. They typically require integrated logistics solutions that ensure the integrity and security of products from manufacturing to delivery. Conversely, third party logistics providers are emerging as vital components of the distribution framework, providing comprehensive and flexible logistics solutions that accommodate the evolving demands of the pharmaceutical landscape. Their expertise in handling temperature-sensitive goods and their ability to streamline operations make them increasingly valuable, especially as the industry shifts towards outsourcing logistics functions.

### By Mode of Transportation: Air Freight (Largest) vs. Road Freight (Fastest-Growing)

In the North America Pharmaceutical Logistics Market, the Mode of Transportation segment showcases a diverse landscape with Air Freight leading in market share due to its efficiency and speed, essential for the temperature-sensitive nature of pharmaceuticals. Following closely, Road Freight continues to hold a significant share, supported by robust infrastructure and expanding distribution networks. Sea and Rail Freight, while present, represent smaller shares reflecting their slower delivery times.

Air Freight (Dominant) vs. Road Freight (Emerging)

Air Freight stands as the dominant force in pharmaceutical logistics, favored for its rapid transit capabilities, which are critical for time-sensitive deliveries. This mode ensures that temperature-sensitive drugs are maintained in optimal conditions during transit. Conversely, Road Freight is emerging, driven by advancements in logistics technology and increasing demand for last-mile delivery solutions. With the rise of e-commerce, Road Freight is adapting quickly, allowing for greater flexibility and shorter delivery times, thus appealing to pharmaceutical companies seeking efficient distribution methods.

### By Temperature Control: Refrigerated Temperature (Largest) vs. Frozen Temperature (Fastest-Growing)

In the North America Pharmaceutical Logistics Market, the distribution of temperature control segments reveals the dominance of refrigerated temperature solutions. This segment is crucial for maintaining the efficacy of a significant share of pharmaceutical products that require stable conditions. Ambient temperature options hold a smaller but important portion of the market, typically utilized for products that are less sensitive to temperature fluctuations. The varied needs of pharmaceuticals are pushing advancements in logistics solutions to cater to these distinct temperature requirements. 
The growth trends in this segment are primarily driven by increasing demand for temperature-sensitive medications, including biologics and vaccines. As healthcare providers focus more on patient safety and product integrity, the refrigerated and frozen segments are witnessing exponential growth. Rising regulatory pressures and the need for reliable cold chain logistics further fuel this momentum, with companies innovating to enhance their service offerings to maintain a competitive edge in this expanding market.

Refrigerated Temperature (Dominant) vs. Frozen Temperature (Emerging)

Refrigerated temperature logistics remain the dominant force in the pharmaceutical sector, primarily due to their critical role in preserving the efficacy of temperature-sensitive medications. This segment includes solutions such as refrigerated trucks and warehousing, which ensure that products are transported and stored under controlled conditions. The infrastructure supporting refrigerated logistics is well-established, allowing for reliable delivery across a wide range of pharmaceutical products. On the other hand, the frozen temperature segment is emerging rapidly, spurred by the growing need for advanced therapies and biologics that often require sub-zero conditions. As innovations in freezing techniques and technologies continue to develop, this segment is attracting investment and attention, positioning itself as a vital player in ensuring the safe distribution of temperature-sensitive pharmaceuticals in North America.

### By Service Type: Transportation Services (Largest) vs. Warehousing Services (Fastest-Growing)

The North America Pharmaceutical Logistics Market is characterized by a diverse range of service types, majorly dominated by Transportation Services. This segment captures the bulk of the market share due to its critical role in ensuring timely delivery and compliance with stringent regulations. Following closely, Warehousing Services are witnessing considerable growth as pharmaceutical companies increasingly emphasize storage solutions that guarantee product integrity and adhere to safety standards.

Transportation Services (Dominant) vs. Inventory Management (Emerging)

Transportation Services remain the dominant player in the North America Pharmaceutical Logistics Market, as they are essential for maintaining the supply chain's efficiency. This segment encompasses various modes of transportation, including air, road, and rail, ensuring pharmaceuticals reach their destinations without compromising quality. In contrast, Inventory Management is emerging as a vital service, driven by the need for better control and visibility over pharmaceutical stock levels. This growth is fueled by advancements in technology and automation that enhance operational efficiencies, thereby supporting the overarching goal of reliable pharmaceutical distribution.

## Regional Market Share Analysis

### US : Leading Market Share and Innovation

The US pharmaceutical logistics market holds a commanding 24.0% share, reflecting a robust value driven by increasing healthcare demands and technological advancements. Key growth drivers include the rise in e-commerce for pharmaceuticals, stringent regulatory frameworks, and government initiatives aimed at improving healthcare access. The infrastructure is well-developed, with advanced cold chain logistics and distribution networks facilitating efficient delivery of temperature-sensitive products.

### Canada : Strategic Developments in Logistics

Canada's pharmaceutical logistics market, with a share of 4.76%, is poised for growth driven by increasing healthcare expenditures and a focus on improving supply chain efficiencies. Demand trends indicate a rising need for specialized logistics services, particularly for biologics and personalized medicine. Government initiatives are enhancing regulatory compliance and fostering innovation in logistics practices, while infrastructure improvements are underway to support these developments.

## Competitive Benchmarking

The Pharmaceutical Logistics Market in North America is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on operational efficiency. Key players such as McKesson Corporation (US), AmerisourceBergen Corporation (US), and UPS Healthcare (US) are actively pursuing strategies that enhance their market positioning. McKesson Corporation (US) emphasizes digital transformation and supply chain optimization, aiming to streamline operations and improve service delivery. AmerisourceBergen Corporation (US) focuses on strategic acquisitions to expand its service offerings and geographic reach, while UPS Healthcare (US) is investing in advanced logistics solutions to cater to the growing demand for temperature-sensitive pharmaceuticals. Collectively, these strategies contribute to a dynamic competitive environment where agility and responsiveness are paramount.
The market structure appears moderately fragmented, with several key players exerting considerable influence. Business tactics such as localizing manufacturing and optimizing supply chains are prevalent among these companies, allowing them to respond swiftly to market demands. The competitive dynamics suggest that while no single entity dominates, the collective strength of these major players shapes the overall market landscape, fostering an environment ripe for innovation and collaboration.
In December 2025, McKesson Corporation (US) announced a partnership with a leading technology firm to enhance its supply chain visibility through advanced analytics. This strategic move is likely to bolster McKesson's operational efficiency, enabling real-time tracking of pharmaceutical shipments and reducing the risk of disruptions. Such initiatives are indicative of a broader trend towards leveraging technology to improve logistics processes.
In November 2025, AmerisourceBergen Corporation (US) completed the acquisition of a regional logistics provider, thereby expanding its footprint in the Northeast. This acquisition not only enhances AmerisourceBergen's distribution capabilities but also positions the company to better serve its clients in a rapidly evolving market. The strategic importance of this move lies in its potential to increase market share and improve service delivery in a competitive landscape.
In October 2025, UPS Healthcare (US) launched a new temperature-controlled logistics service aimed at supporting the distribution of biologics and other sensitive pharmaceuticals. This initiative reflects UPS's commitment to meeting the growing demand for specialized logistics solutions. The introduction of such services is crucial as it aligns with the industry's shift towards more complex supply chain requirements, particularly for high-value products.
As of January 2026, current trends in the Pharmaceutical Logistics Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into logistics operations. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and enhancing service offerings. The evolution of competitive differentiation appears to be shifting from price-based competition towards a focus on technological advancements, supply chain reliability, and innovative solutions. This transition suggests that companies that prioritize these aspects are likely to gain a competitive edge in the future.

## Recent News & Developments

**In April 2023** when Panalpina, one of the prominent logistics service providers, also received news of its intention to merge with DHL Supply Chain. This strategy is focused on elevating the logistics performance of the pharmaceutical firms, particularly the cold chain logistics of such temperature-sensitive products. By means of the merger, operational efficiency and the logistics network in North America will be improved.

Looking at the **July 2023** picture, McKesson Corporation completed the purchase of Change Healthcare. This $13 Billion acquisition targets improvement of healthcare logistics, especially in the distribution of pharmaceutical products. The Partners also intend to improve supply chain visibility and better healthcare by employing Change healthcare within its supply chain.

The month of **September 2023** came along with announcements from AmerisourceBergen on their partnership with Celerion, a contract research organization (CRO) for the enhancement of clinical trial supply logistics. This partnership works on switching the supply of drugs to research centers and clinical sites and minimizes the time lost in getting medicines needed for studies. This partnership is likely to enhance their abilities in the management of complex logistics during clinical studies.

**In January 2024,** Cardinal Health and Genentech signed a merger agreement intending to improve their collaboration in the area of supply chain management. As a result of the merger, a powerful company focusing on logistics and the supply chain of biopharmaceuticals would be created with a special concentration on specialty pharmaceuticals where distribution is the essence of the product​.

Also, Ryder System, Inc. announced plans of acquisition of C3S, a pharmaceutical logistics provider, in February 2024. This acquisition is likely to add more value to Ryder’s portfolio as well as help increase the range of services offered, especially in the area of temperature-controlled logistics essential for the pharmaceutical industry​.

## Report Scope

| MARKET SIZE 2024 | 28.76(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 33.16(USD Billion) |
| MARKET SIZE 2035 | 71.28(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.6% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), UPS Healthcare (US), FedEx Corporation (US), DHL Supply Chain (US), Thermo Fisher Scientific Inc. (US), Panalpina (US) |
| Segments Covered | Application, End Use, Mode of Transportation, Temperature Control, Service Type |
| Key Market Opportunities | Integration of advanced technologies enhances efficiency in the North America Pharmaceutical Logistics Market. |
| Key Market Dynamics | Rising demand for temperature-controlled logistics solutions drives innovation in North America's Pharmaceutical Logistics Market. |
| Countries Covered | US, Canada |

## Frequently Asked Questions

**Q: What is the current valuation of the North America Pharmaceutical Logistics Market?**
A: As of 2024, the market valuation was 28.76 USD Billion.

**Q: What is the projected market size for the North America Pharmaceutical Logistics Market by 2035?**
A: The market is projected to reach 71.28 USD Billion by 2035.

**Q: What is the expected CAGR for the North America Pharmaceutical Logistics Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 8.6%.

**Q: Which companies are considered key players in the North America Pharmaceutical Logistics Market?**
A: Key players include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, UPS Healthcare, FedEx Corporation, DHL Supply Chain, Thermo Fisher Scientific, and Panalpina.

**Q: What are the main segments of the North America Pharmaceutical Logistics Market by application?**
A: The main segments by application include Cold Chain Logistics, Non-Cold Chain Logistics, Pharmaceutical Warehousing, and Transportation Management.

**Q: How did the Cold Chain Logistics segment perform in terms of valuation?**
A: The Cold Chain Logistics segment was valued between 8.0 and 20.0 USD Billion.

**Q: What is the valuation range for the Transportation Management segment?**
A: The Transportation Management segment had a valuation range of 5.76 to 11.28 USD Billion.

**Q: Which end-use segment had the highest valuation in the North America Pharmaceutical Logistics Market?**
A: The Pharmaceutical Manufacturers segment had the highest valuation, ranging from 10.0 to 25.0 USD Billion.

**Q: What modes of transportation are included in the North America Pharmaceutical Logistics Market?**
A: The market includes Air Freight, Sea Freight, Road Freight, and Rail Freight as modes of transportation.

**Q: What temperature control segments are present in the North America Pharmaceutical Logistics Market?**
A: The temperature control segments include Ambient Temperature, Refrigerated Temperature, and Frozen Temperature.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/north-america-pharmaceutical-logistics-market-21532*